Freedom of Information request (FOI 22/1164)
Published 17 January 2024
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-12-december-2022/freedom-of-information-request-foi-221164
FOI 22/1164
14th December 2022
Dear
Thank you for your communication, dated 2nd December 2022, in which you requested the following information:
‘if the medicinal products Tazocin 4 g/0.5 g and Tazocin 2 g/0.25 g (piperacillin and tazobactam) by Pfizer Limited has a Risk Management Plan in place?
If yes, I would be grateful if you could share the list of safety concerns presented in that RMP or summary RMP. If possible, please let me know if any of the safety concerns has:
- a specific follow-up questionnaire,
- additional PV activities or additional risk minimization measures.’
Regarding your request for the Risk Management Plan (RMP), as the Marketing Authorisation application for Tazocin 4 g/0.5 g and Tazocin 2 g/0.25 g (piperacillin and tazobactam) was made prior to the 2012 amendment in pharmacovigilance legislation, which requires an RMP for all new applications, the MHRA does not hold an RMP for this product.
We hope you find this helpful. If you have a query about the information provided, please reply to this email.
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: info@mhra.gov.uk
Please remember to quote the reference number above in any future communications.
If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:
Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF Yours sincerely
FOI Team,
Safety and Surveillance